scispace - formally typeset
J

Jee Hyun Kim

Researcher at Seoul National University Bundang Hospital

Publications -  703
Citations -  12600

Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications receiving 9907 citations. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.

Papers
More filters
DOI

Analysis of Low-Frequency Noise in Quantum Dot/Metal-Oxide Phototransistors With Metal Chalcogenide Interfaces

Jee Hyun Kim, +3 more
- 01 Sep 2022 - 
TL;DR: Low-frequency noise measurements are carried out to investigate optoelectronic characteristics of CdSe quantum dot (QD)/indium-gallium-zinc-oxide (IGZO) heterostructured hybrid phototransistor with respect to various QD surface ligands and it is found that the lowfrequency noise properties are dominant for chalcometallate ligands.
Journal ArticleDOI

Difference in Subfoveal Choroidal Thickness between Two Spectral-Domain Optical Coherence Tomography Systems

Jee Hyun Kim, +4 more
- 01 Sep 2014 - 
TL;DR: Subfoveal choroidal thickness measurements according to Heidelberg Spectralis and Cirrus HD-OCT in both normal eyes and eyes with retinal diseases showed no significant differences.
Journal ArticleDOI

Efficient Oxygen‐Vacancy Suppression and Electrical Stabilization of Solution‐Processed In2O3:Q (Q = S, Se) Thin‐Film Transistor with Chalcogen Alloying

P. Lee, +9 more
- 09 Feb 2022 - 
TL;DR: In this paper , a material design strategy for realizing a high-performance oxide semiconductor for TFTs through partial substitution of Se or S for O in In2O3 is reported.
Proceedings ArticleDOI

Rarity Score : A New Metric to Evaluate the Uncommonness of Synthesized Images

Jiyeon Han, +5 more
TL;DR: A new evaluation metric, called ‘rarity score’, is proposed, to measure the individual rarity of each image synthesized by generative models, and a method to compare rarities between datasets that share the same concept such as CelebA-HQ and FFHQ is proposed.
Journal ArticleDOI

A randomized phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.

Jin Won Kim, +8 more
- 25 May 2020 - 
TL;DR: A small number of patients with locally advanced or metastatic biliary tract cancer who have received second-line chemotherapy with or without prior treatment with mFOLFOX are enrolled in a double-blind, placebo-controlled trial to evaluate the safety and effectiveness of this drug.